15:00 CET
Webcast to review the Interim Report Q2 2019
The Interim Report Q2 2019 and an operational update will be presented by CEO Jakob Lindberg and members of Oncopeptides management team, Wednesday August 28, 2019 at 15:00 (CET). The conference call will also be streamed via a link on the website: www.oncopeptides.com.
Phone numbers for participants from:
Sweden: +46 8 505 583 59
Europe: +44 3333 009 032
USA: +1 833 823 05 90
See link to the webcast: https://tv.streamfabriken.com/oncopeptides-q2-2019
Upcoming events
Webcast - Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US
09:00 CET
January 21, 2022, Oncopeptides announced that the Company has contacted the US Food and Drug Administration and rescinded the October 22, 2021, letter requesting voluntary withdrawal of the NDA of Pepaxto® in the US. Investors, financial analysts and media are invited to participate in a webcast with a Q&A session on January 24, 2022, at 09:00 (CET).